The FDA Center for Tobacco Products (CTP) is responsible for carrying out the Family Smoking Prevention and Tobacco Control Act, which Congress passed in 2009. This law—commonly called the Tobacco Control Act—gives us broad authority to regulate the manufacturing, distribution, and marketing of tobacco products. Our goal is to reduce the harm from all regulated tobacco products across the entire population, including:
- reducing the number of people who start to use tobacco products
- encouraging more people to stop using these products
- reducing the adverse health impact for those who continue to use these products.
FDA’s unique position as a regulatory agency allows for a framework of decision-making based on – and within the limits of – both the science and the law. CTP uses a comprehensive approach as the best way to end the negative health effects of tobacco use. This includes defining policy, issuing regulations, conducting research, educating Americans on regulated tobacco products and making decisions on whether new products and claims can be marketed—including reviewing and evaluating applications and claims before the products are allowed on the market. This cohesive, comprehensive approach can help us reach our goals of preventing people from starting to use tobacco products, encouraging tobacco users to quit and reducing the harm caused by tobacco use. As we work to protect the public’s health, we will use the full power of the law to protect consumers from the dangers of tobacco use.
To view current openings at CTP, CLICK HERE